- Pénzügyi szolgáltatás
Manifold Bio
In vivo drug discovery engine for targeted biologics.
Bemutatkozás
Manifold Bio operates the first high-throughput in vivo (HTV) discovery engine, integrating massively multiplexed in vivo screening and AI-powered design to create targeted biologics. The company addresses the challenge of in vitro assays failing to capture the complexity of living systems by sculpting pharmacokinetics and biodistribution directly in living systems using their mDesign engine. Key technologies include mCodes, which are multiplexed protein barcodes measured via NGS to quantify hundreds of candidate molecules across tissues in a single animal, and generative AI models for protein design. The company is developing a pipeline of CNS-targeted biologics for conditions like Alzheimer's and Parkinson's, as well as peripheral-targeted candidates for cardiometabolic disease, through internal development and strategic partnerships.
Szolgáltatások, tevékenységek
- AI antibody design for in vivo-first discovery
- High-throughput in vivo (HTV) discovery engine operation
- AI-guided protein design (Generative Design)
- Molecular tracking using mCodes
- In vivo shuttle engineering and optimization (mShuttle Portfolio)
- Development of CNS-targeted biologics (Abeta, tau, aSyn)
- Development of Peripheral-targeted biologics (Cardiometabolic disease)
- IND-enabling studies for drug candidates
- Partnership for co-design of precision biologics